CRH (CRH) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Feb, 2026Executive summary
Achieved record financial performance in 2025, with total revenues of $37.4 billion (+5% YoY), double-digit Adjusted EBITDA growth (+11% YoY), and 12th consecutive year of margin expansion, driven by strong end-market demand, pricing, and acquisitions.
Invested $4.1 billion in 38 acquisitions and $1.7 billion in high-return growth CapEx, supporting organic and inorganic growth.
Returned $2.2 billion to shareholders via $1 billion in dividends and $1.2 billion in share buybacks, continuing a 42-year streak of dividend growth.
Outperformed the S&P 500 in total shareholder return over 1, 10, and 55 years; included in the S&P 500 Index.
Positive outlook for 2026, with expected Adjusted EBITDA of $8.1–$8.5 billion.
Financial highlights
Full-year 2025 revenues reached $37.4 billion (+5% YoY), with Q4 revenues at $9.4 billion (+6% YoY), driven by end-market demand and acquisitions.
Adjusted EBITDA was $7.7 billion (+11% YoY), with Q4 at $2.0 billion (+14% YoY); margin improved to 20.5% (+100bps YoY).
Diluted EPS for FY 2025 was $5.51 (+10% YoY); pre-impairment EPS was $5.57 (+3% YoY).
Adjusted Free Cash Flow was $5.0 billion (+18% YoY), with a 130% conversion ratio of net income.
Net cash from operating activities was $5.6 billion (+13% YoY).
Outlook and guidance
2026 guidance: Adjusted EBITDA of $8.1–$8.5 billion, net income of $3.9–$4.1 billion, diluted EPS of $5.60–$6.05.
Capital expenditure expected at $2.8–$3.0 billion; effective tax rate of 24%; average diluted share count of 675 million.
2030 targets: 7–9% annual revenue growth, Adjusted EBITDA margin of 22–24%, and over 100% Adjusted Free Cash Flow conversion.
Positive outlook supported by robust infrastructure funding, strong demand in transportation, water, reindustrialization, and resilient repair/remodel activity.
Guidance includes $200 million incremental EBITDA from 2025 acquisitions, offset by a divestiture.
Latest events from CRH
- Record financials, capital structure simplification, and key governance proposals for 2026 AGM.CRH
Proxy Filing13 Mar 2026 - Delisting and preference share cancellations aim to simplify capital structure and cut costs.CRH
Proxy Filing13 Mar 2026 - Q2 net income up 8%, EBITDA up 12%, margins expanded, and FY24 guidance raised.CRH
H1 20242 Feb 2026 - Q3 saw strong sales, margin gains, and M&A, with a positive outlook reaffirmed.CRH
Q3 2024 TU16 Jan 2026 - Double-digit profit growth and margin expansion achieved, with strong 2025 outlook.CRH
H2 20247 Jan 2026 - Record Q3, raised FY25 EBITDA guidance, and strong outlook driven by demand and acquisitions.CRH
Q3 2025 TU21 Dec 2025 - Record financials, new equity plan, governance updates, and strong ESG progress headline the proxy.CRH
Proxy Filing2 Dec 2025 - Record results, NYSE transition, new CEO, and 12 key AGM proposals mark a transformative year.CRH
Proxy Filing2 Dec 2025 - Definitive additional proxy materials filed for upcoming shareholder meeting.CRH
Proxy Filing2 Dec 2025